For Immediate Release: May 27, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 26, the FDA posted warning letters to multiple companies illegally selling CBD products intended for …
For Immediate Release: May 26, 2022 Today, the U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with …
For Immediate Release: May 24, 2022 Today, the U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. “We continue to …
For Immediate Release: May 24, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 23, the FDA announced the availability of one final guidance and two draft guidances for blood …
For Immediate Release: May 20, 2022 Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 …
For Immediate Release: May 20, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On May 19, the FDA issued responses to two food additive petitions and a citizen petition requesting agency …
For Immediate Release: May 19, 2022 Statement From: Patrizia Cavazzoni, M.D. Director - Center for Drug Evaluation and Research Drug shortages pose a significant public health threat as they can delay, and in some cases, even deny critically needed care …
For Immediate Release: May 19, 2022 Today, the U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the …
For Immediate Release: May 17, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Seeks to Engage Stakeholders on Key Considerations for a Drug …
For Immediate Release: May 17, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 …
For Immediate Release: May 16, 2022 Today, the U.S. Food and Drug Administration is announcing a guidance that outlines increased flexibilities regarding importation of certain infant formula products to further increase the availability of infant formula …
For Immediate Release: May 16, 2022 The U.S. Food and Drug Administration is announcing important updates on its ongoing work to increase the supply and availability of infant formula in the U.S. On Feb. 17, the agency warned consumers not to use certain …
FDA News Release The EUA authorizes at-home sample collection with testing performed in a laboratory For Immediate Release: May 16, 2022 Today, the U.S. Food and Drug Administration authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use …
For Immediate Release: May 13, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA advised consumers about the risk of accidental ingestion, especially by children, of edible …
For Immediate Release: May 13, 2022 Today, the U.S. Food and Drug Administration approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. Mounjaro was effective at …
For Immediate Release: May 10, 2022 Today, the U.S. Food and Drug Administration is providing an update on its work to increase the availability of infant and specialty formula products. On Feb. 17, the agency warned consumers not to use certain powdered …
For Immediate Release: May 10, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved a new indication for Olumiant (baricitinib) for the treatment of COVID-19 in …
For Immediate Release: August 05, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA cautioned pet owners not to feed their pets certain lots of Darwin’s Natural Pet …
For Immediate Release: August 05, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. …
For Immediate Release: August 05, 2022 Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other …
03 days 20:38:40
